Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Robbins

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Cancer Immunology Research|September 6, 2019
Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell TherapyYong-Chen Lu, Li Jia, Zhili Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell linesYangbing Zhao, Zhili Zheng, Paul F Robbins, et al.
Cancer Research|March 9, 2005
Bcl-2 overexpression enhances tumor-specific T-cell survivalJehad Charo, Steven E Finkelstein, Navrose Grewal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanomaPaul F Robbins, Mona El-Gamil, Yong F Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomeraseMaria R Parkhurst, John P Riley, Takehito Igarashi, et al.
Science Immunology|January 13, 2019
Tumor-infiltrating human CD4<sup>+</sup> regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivityMojgan Ahmadzadeh, Anna Pasetto, Li Jia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene productJianping Huang, Mona El-Gamil, Mark E Dudley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cellsMaria R Parkhurst, Jayne Joo, John P Riley, et al.
Cancer Research|April 19, 2007
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bondCyrille J Cohen, Yong F Li, Mona El-Gamil, et al.
Human Pathology|December 3, 2013
Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanomaPhyu P Aung, Yen-Chun Liu, Leomar Y Ballester, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Cancer Immunology Research|September 6, 2019
Single-Cell Transcriptome Analysis Reveals Gene Signatures Associated with T-cell Persistence Following Adoptive Cell TherapyYong-Chen Lu, Li Jia, Zhili Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Primary human lymphocytes transduced with NY-ESO-1 antigen-specific TCR genes recognize and kill diverse human tumor cell linesYangbing Zhao, Zhili Zheng, Paul F Robbins, et al.
Cancer Research|March 9, 2005
Bcl-2 overexpression enhances tumor-specific T-cell survivalJehad Charo, Steven E Finkelstein, Navrose Grewal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2002
Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanomaPaul F Robbins, Mona El-Gamil, Yong F Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Immunization of patients with the hTERT:540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomeraseMaria R Parkhurst, John P Riley, Takehito Igarashi, et al.
Science Immunology|January 13, 2019
Tumor-infiltrating human CD4<sup>+</sup> regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivityMojgan Ahmadzadeh, Anna Pasetto, Li Jia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
T cells associated with tumor regression recognize frameshifted products of the CDKN2A tumor suppressor gene locus and a mutated HLA class I gene productJianping Huang, Mona El-Gamil, Mark E Dudley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Characterization of genetically modified T-cell receptors that recognize the CEA:691-699 peptide in the context of HLA-A2.1 on human colorectal cancer cellsMaria R Parkhurst, Jayne Joo, John P Riley, et al.
Cancer Research|April 19, 2007
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bondCyrille J Cohen, Yong F Li, Mona El-Gamil, et al.
Human Pathology|December 3, 2013
Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanomaPhyu P Aung, Yen-Chun Liu, Leomar Y Ballester, et al.
Pageof 13